The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Open accessAbstract
Combination regimens that include artemisinin derivatives are recommended as first line antimalarials in most countries where malaria is endemic. However, the mechanism of action of artemisinin is not fully understood and the usefulness of this drug class is threatened by reports of decreased parasite sensitivity. We treated Plasmodium falciparum for periods of a few hours to mimic clinical exposure to the short half-life artemisinins. We found that drug treatment retards parasite growth and inhibits uptake of hemoglobin, even at sublethal concentrations. We show that potent artemisinin activity is dependent on hemoglobin digestion by the parasite. Inhibition of hemoglobinase activity with cysteine protease inhibitors, knockout of the cysteine protease falcipain-2 by gene deletion, or direct deprivation of host cell lysate, significantly decreases artemisinin sensitivity. Hemoglobin digestion is also required for artemisinin-induced exacerbation of oxidative stress in the parasite cytoplasm. Arrest of hemoglobin digestion by early stage parasites provides a mechanism for surviving short-term artemisinin exposure. These insights will help in the design of new drugs and new treatment strategies to circumvent drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
LeBel, C. P., Ischiropoulos, H., & Bondy, S. C. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00026a012 · Cited by 2,689
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Artemisinin: mechanisms of action, resistance and toxicity
Meshnick, S. R. (2002) · International Journal for Parasitology · doi:10.1016/s0020-7519(02)00194-7 · Cited by 720
Artemisinin-Based Combination Treatment of Falciparum Malaria
Nosten, F., & White, N. J. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.181 · Cited by 673
Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions
Becker, K., Tilley, L., Vennerstrom, J. L., Roberts, D., Rogerson, S., & Ginsburg, H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.09.011 · Cited by 652
Self-citationArtemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
A Medicinal Chemistry Perspective on Artemisinin and Related Endoperoxides
O'Neill, P. M., & Posner, G. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030571c · Cited by 538
Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
Liu, J., Istvan, E. S., Gluzman, I. Y., Gross, J., & Goldberg, D. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601876103 · Cited by 344
Cysteine proteases of malaria parasites
Rosenthal, P. J. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.003 · Cited by 318
Self-citationIncreased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
Terkuile, F., White, N. J., Holloway, P., Pasvol, G., & Krishna, S. (1993) · Experimental Parasitology · doi:10.1006/expr.1993.1010 · Cited by 290
Sijwali, P. S., & Rosenthal, P. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307720101 · Cited by 276
Self-citationTeuscher, F., Gatton, M. L., Chen, N., Peters, J., Kyle, D. E., & Cheng, Q. (2010) · The Journal of Infectious Diseases · doi:10.1086/656476 · Cited by 255
[4] Preparation of derivatives of ferrous and ferric hemoglobin
Di Iorio, E. E. (1981) · Methods in Enzymology · doi:10.1016/0076-6879(81)76114-7 · Cited by 246
Bakar, N. A., Klonis, N., Hanssen, E., Chan, C., & Tilley, L. (2010) · Journal of Cell Science · doi:10.1242/jcs.061499 · Cited by 204
Self-citationHeme as Trigger and Target for Trioxane-Containing Antimalarial Drugs
Meunier, B., & Robert, A. (2010) · Accounts of Chemical Research · doi:10.1021/ar100070k · Cited by 183
Krungkrai, S. R., & Yuthavong, Y. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90003-4 · Cited by 176
Clinical Pharmacology of Artemisinin-Based Combination Therapies
Aweeka, F. T., & German, P. I. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847020-00002 · Cited by 162
Mercer, A. E., Copple, I. M., Maggs, J. L., O'Neill, P. M., & Park, B. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144188 · Cited by 161
Sijwali, P. S., Koo, J., Singh, N. P., & Rosenthal, P. J. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.06.013 · Cited by 152
Self-citationHartwig, C. L., Rosenthal, A. S., D’Angelo, J. G., Griffin, C. E., Posner, G. H., & Cooper, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.015 · Cited by 147
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs
Skinner‐Adams, T. S., Manning, L. S., Johnston, W. A., & Davis, T. M. E. (1996) · International Journal for Parasitology · doi:10.1016/0020-7519(96)89380-5 · Cited by 131
Antimalarial Quinolines and Artemisinin Inhibit Endocytosis in Plasmodium falciparum
Hoppe, H. C., van Schalkwyk, D. A., Wiehart, U. I. M., Meredith, S. A., Egan, J., & Weber, B. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2370-2378.2004 · Cited by 128
Effect of Antimalarial Drugs onPlasmodium falciparumGametocytes
Peatey, C. L., Skinner‐Adams, T. S., Dixon, M. W. A., McCarthy, J. S., Gardiner, D. L., & Trenholme, K. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/644645 · Cited by 127
Chavchich, M., Gerena, L., Peters, J. M., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00947-09 · Cited by 125
Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum
Imwong, M., Dondorp, A. M., Nosten, F. H., Yi, P., Mungthin, M., Hanchana, S., Das, D., Phyo, A. P., Lwin, K. M., Pukrittayakamee, S., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00032-10 · Cited by 123
Plasmodium Food Vacuole Plasmepsins Are Activated by Falcipains
Drew, M. E., Banerjee, R., Uffman, E. W., Gilbertson, S. R., Rosenthal, P. J., & Goldberg, D. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708949200 · Cited by 121
Self-citationMalaria's Drug Miracle in Danger
Enserink, M. (2010) · Science · doi:10.1126/science.328.5980.844 · Cited by 114
Three-dimensional reconstruction of the feeding process of the malaria parasite.
Slomianny, C. (1990) · PubMed · Cited by 112
Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series
Coterón, J. M., Catterick, D., Castro, J., Chaparro, M. J., Díaz, B., Fernández, E., Ferrer, S. B., Gamo, F., Gordo, M., Gut, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100556b · Cited by 108
Self-citationPeroxide Bond-Dependent Antiplasmodial Specificity of Artemisinin and OZ277 (RBx11160)
Kaiser, M., Wittlin, S., Nehrbass-Stuedli, A., Dong, Y., Wang, X., Hemphill, A. F., Matile, H., Brun, R., & Vennerstrom, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00225-07 · Cited by 95
Haynes, R. K., Chan, W., Wong, H. N., Li, K., Wu, W., Fan, K. M., Sung, H. H. Y., Williams, I. D., Prosperi, D., Melato, S., et al. (2010) · ChemMedChem · doi:10.1002/cmdc.201000225 · Cited by 88
Artemisinins and the biological basis for the PfATP6/SERCA hypothesis
Krishna, S., Pulcini, S., Fatih, F. A., & Staines, H. M. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.06.014 · Cited by 76
Fu, Y., Tilley, L. M., Kenny, S., & Klonis, N. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20856 · Cited by 63
Self-citationQinghaosu-mediated oxidation in normal and abnormal erythrocytes.
Scott, M. D., Meshnick, S. R., Williams, R. A., Chiu, D., Pan, H. C., Lubin, B. H., & Kuypers, F. A. (1989) · PubMed · Cited by 46
Cited by
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Straimer, J., Gnädig, N. F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A. P., Dacheux, M., Khim, N., Zhang, L., Lam, S., et al. (2015) · Science · doi:10.1126/science.1260867 · Cited by 728
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R. V., Rizk, S. S., Njimoh, D. L., Ryan, Y., Chotivanich, K., et al. (2015) · Nature · doi:10.1038/nature14412 · Cited by 597
Malaria biology and disease pathogenesis: insights for new treatments
Miller, L. H., Ackerman, H. C., Su, X.-Z., & Wellems, T. E. (2013) · Nature Medicine · doi:10.1038/nm.3073 · Cited by 582
Metadata
- Authors
- Klonis, N., Crespo-Ortiz, M. P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P. J., & Tilley, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-06-27
- Volume
- 108
- Issue
- 28
- Pages
- 11405-11410
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023633070
- Cited by
- 333
- References
- 42
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.